Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amneal Pharmaceuticals Inc 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 USA

www.amneal.com Employees: 8,500 P: 908-947-3120 F: 908-947-3146

Sector:

Medical

Description:

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,027,251
Enterprise Value, $K 6,365,552
Shares Outstanding, K 314,629
Float, K 231,064
% Float 73.44%
Short Interest, K 10,841
Short Float 3.45%
Days to Cover 4.51
Short Volume Ratio 0.74
% of Insider Shareholders 26.56%
% of Institutional Shareholders 31.82%

Financials:

Annual Sales, $ 3,019 M
Annual Net Income, $ 72,060 K
Last Quarter Sales, $ 814,320 K
Last Quarter Net Income, $ 35,080 K
EBIT, $ 392,080 K
EBITDA, $ 638,080 K

Growth:

1-Year Return 79.91%
3-Year Return 822.06%
5-Year Return 112.90%
5-Year Revenue Growth 51.50%
5-Year Earnings Growth 44.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.21 on 02/27/26
Next Earnings Date 05/01/26 [BMO]
Earnings Per Share ttm 0.76
EPS Growth vs. Prev Qtr 26.67%
EPS Growth vs. Prev Year 90.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AMRX Ratios

Ratio
Price/Earnings ttm 16.72
Price/Earnings forward 13.97
Price/Earnings to Growth N/A
Return-on-Equity % -228.24%
Return-on-Assets % 6.91%
Profit Margin % 2.39%
Debt/Equity -36.06
Price/Sales 1.32
Price/Cash Flow 8.14
Price/Book N/A
Book Value/Share -0.23
Interest Coverage -1.58
60-Month Beta 1.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.